MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Parr, Callum J C ^a   Katayama, Shota ^a   Miki, Kenji ^a   Kuang, Yi ^a   Yoshida, Yoshinori ^a   Morizane, Asuka ^a   Takahashi, Jun ^a   Yamanaka, Shinya ^a,b   Saito, Hirohide ^a  

^a KYOTO UNIVERSITY   (Japan)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN302 MICRORNA, HUMAN;

CELL DIFFERENTIATION; CELL LINEAGE; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; NUCLEAR REPROGRAMMING; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

CELL DIFFERENTIATION; CELL LINEAGE; CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; STEM CELL TRANSPLANTATION;

EID: 84986905954     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32532     Document Type: Article

References (60)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676, doi: 10. 1016/j. cell. 2006. 07. 024 (2006).
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi: 10. 1016/j. cell. 2007. 11. 019 (2007).
3. Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275-280, doi: 10. 1038/nbt. 1529 (2009).
4. Morizane, A., Doi, D., Kikuchi, T., Nishimura, K. & Takahashi, J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res 89, 117-126, doi: 10. 1002/jnr. 22547 (2011).
5. Morizane, A., Doi, D. & Takahashi, J. Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free floating aggregation culture. Methods Mol Biol 1018, 11-19, doi: 10. 1007/978-1-62703-444-9-2 (2013).
6. Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107, 4335-4340, doi: 10. 1073/pnas. 0910012107 (2010).
7. Narsinh, K. H. et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121, 1217-1221, doi: 10. 1172/JCI44635 (2011).
8. Koyanagi-Aoi, M. et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci USA 110, 20569-20574, doi: 10. 1073/pnas. 1319061110 (2013).
9. Ohnuki, M. et al. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proc Natl Acad Sci USA 111, 12426-12431, doi: 10. 1073/pnas. 1413299111 (2014).
10. Hentze, H. et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2, 198-210, doi: 10. 1016/j. scr. 2009. 02. 002 (2009).
11. Gropp, M. et al. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. Plos One 7, e45532, doi: 10. 1371/journal. pone. 0045532 (2012).
12. Miki, K. et al. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. Cell Stem Cell 16, 699-711, doi: 10. 1016/j. stem. 2015. 04. 005 (2015).
13. Endo, K., Hayashi, K. & Saito, H. High-resolution Identification and Separation of Living Cell Types by Multiple microRNAresponsive Synthetic mRNAs. Sci Rep 6, 21991, doi: 10. 1038/srep21991 (2016).
14. Houbaviy, H. B., Murray, M. F. & Sharp, P. A. Embryonic stem cell-specific MicroRNAs. Dev Cell 5, 351-358 (2003).
15. Barroso-del Jesus, A., Lucena-Aguilar, G. & Menendez, P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 8, 394-398 (2009).
16. Laurent, L. C. et al. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells 26, 1506-1516, doi: 10. 1634/stemcells. 2007-1081 (2008).
17. Zhang, Z. et al. Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN. Stem Cell Reports 1, 218-225, doi: 10. 1016/j. stemcr. 2013. 07. 002 (2013).
18. Lipchina, I., Studer, L. & Betel, D. The expanding role of miR-302-367 in pluripotency and reprogramming. Cell Cycle 11, 1517-1523, doi: 10. 4161/cc. 19846 (2012).
19. Zhang, Z. et al. MicroRNA-302/367 cluster governs hESC self-renewal by dually regulating cell cycle and apoptosis pathways. Stem Cell Reports 4, 645-657, doi: 10. 1016/j. stemcr. 2015. 02. 009 (2015).
20. Doi, D. et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports 2, 337-350, doi: 10. 1016/j. stemcr. 2014. 01. 013 (2014).
21. O'Connor, M. D. et al. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 26, 1109-1116, doi: 10. 1634/stemcells. 2007-0801 (2008).
22. Brivanlou, A. H. et al. Stem cells. Setting standards for human embryonic stem cells. Science 300, 913-916, doi: 10. 1126/science. 1082940 (2003).
23. Gertow, K. et al. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol Chapter 1, Unit1B. 4, doi: 10. 1002/9780470151808. sc01b04s3 (2007).
24. Wesselschmidt, R. L. The teratoma assay: an in vivo assessment of pluripotency. Methods Mol Biol 767, 231-241, doi: 10. 1007/978-1-61779-201-4-17 (2011).
25. Ramirez, J. M. et al. Brief report: benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: all markers are not equal. Stem Cells 29, 1469-1474, doi: 10. 1002/stem. 681 (2011).
26. Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25, 803-816, doi: 10. 1038/nbt1318 (2007).
27. Fong, C. Y., Peh, G. S., Gauthaman, K. & Bongso, A. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev 5, 72-80, doi: 10. 1007/s12015-009-9054-4 (2009).
28. Itskovitz-Eldor, J. A panel of glycan cell surface markers define pluripotency state and promote safer cell-based therapies. Cell Stem Cell 9, 291-292, doi: 10. 1016/j. stem. 2011. 09. 005 (2011).
29. Ben-David, U. et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a highthroughput screen. Cell Stem Cell 12, 167-179, doi: 10. 1016/j. stem. 2012. 11. 015 (2013).
30. Kuo, T. F. et al. Selective elimination of human pluripotent stem cells by a marine natural product derivative. J Am Chem Soc 136, 9798-9801, doi: 10. 1021/ja501795c (2014).
31. Tateno, H. et al. Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Reports 4, 811-820, doi: 10. 1016/j. stemcr. 2015. 02. 016 (2015).
32. Huskey, N. E. et al. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Reports 4, 374-389, doi: 10. 1016/j. stemcr. 2015. 01. 019 (2015).
33. Hirata, N. et al. A chemical probe that labels human pluripotent stem cells. Cell Rep 6, 1165-1174, doi: 10. 1016/j. celrep. 2014. 02. 006 (2014).
34. Lee, M. O. et al. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci USA 110, E3281-E3290, doi: 10. 1073/pnas. 1303669110 (2013).
35. Kuroda, T., Yasuda, S. & Sato, Y. In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells. Methods Mol Biol 1210, 183-192, doi: 10. 1007/978-1-4939-1435-7-14 (2014).
36. Kuroda, T. et al. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. Plos One 7, e37342, doi: 10. 1371/journal. pone. 0037342 (2012).
37. Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274-276, doi: 10. 1038/521274a (2015).
38. Prassas, I. & Diamandis, E. P. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research. Clin Chem Lab Med 52, 765-766, doi: 10. 1515/cclm-2013-1078 (2014).
39. Michel, M. C., Wieland, T. & Tsujimoto, G. How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379, 385-388, doi: 10. 1007/s00210-009-0395-y (2009).
40. Egelhofer, T. A. et al. An assessment of histone-modification antibody quality. Nat Struct Mol Biol 18, 91-93, doi: 10. 1038/nsmb. 1972 (2011).
41. Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A. & George, A. J. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov 9, 325-338, doi: 10. 1038/nrd3003 (2010).
42. Gilman, S. et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64, 1553-1562, doi: 10. 1212/01. WNL. 0000159740. 16984. 3C (2005).
43. Salloway, S. et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 370, 322-333, doi: 10. 1056/NEJMoa1304839 (2014).
44. Wroblewska, L. et al. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery. Nat Biotechnol 33, 839-841, doi: 10. 1038/nbt. 3301 (2015).
45. Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414, doi: 10. 1016/j. cell. 2007. 04. 040 (2007).
46. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630, doi: 10. 1016/j. stem. 2010. 08. 012 (2010).
47. Hu, S. et al. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells 31, 259-268, doi: 10. 1002/stem. 1278 (2013).
48. Liao, B. et al. MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem 286, 17359-17364, doi: 10. 1074/jbc. C111. 235960 (2011).
49. Tokunaga, K. et al. Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells. Sci Rep 4, 6996, doi: 10. 1038/srep06996 (2014).
50. Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2, 3081-3089, doi: 10. 1038/nprot. 2007. 418 (2007).
51. Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487-492, doi: 10. 1016/j. stem. 2009. 05. 015 (2009).
52. Gafni, O. et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286, doi: 10. 1038/nature12745 (2013).
53. Rais, Y. et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 502, 65-70, doi: 10. 1038/nature12587 (2013).
54. Parchem, R. J. et al. Two miRNA clusters reveal alternative paths in late-stage reprogramming. Cell Stem Cell 14, 617-631, doi: 10. 1016/j. stem. 2014. 01. 021 (2014).
55. Gu, K. L. et al. Pluripotency-associated miR-290/302 family of microRNAs promote the dismantling of naive pluripotency. Cell Res 26, 350-366, doi: 10. 1038/cr. 2016. 2 (2016).
56. Lee, Y. J. et al. Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency. Cell Regen (Lond) 5, 2, doi: 10. 1186/s13619-016-0028-0 (2016).
57. Jouneau, A. et al. Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles. RNA 18, 253-264, doi: 10. 1261/rna. 028878. 111 (2012).
58. Mullokandov, G. et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 9, 840-846, doi: 10. 1038/nmeth. 2078 (2012).
59. Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 4, 3594, doi: 10. 1038/srep03594 (2014).
60. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001).